BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 3781704)

  • 1. Recent advances of knowledge on the mechanism of action of drugs modifying the bronchial secretions.
    Morandini GC; Perduca M; Finiguerra M; De Martini S; Fraticelli G
    Int J Clin Pharmacol Res; 1986; 6(5):415-23. PubMed ID: 3781704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Rheology of bronchial secretions and mucociliary transport (author's transl)].
    Puchelle E; Girard F; Zahm JM
    Bull Eur Physiopathol Respir; 1976; 12(6):771-9. PubMed ID: 1016804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bronchial expectorants : pharmacology of bronchial mucomodifiers].
    Polu JM; Puchelle E; Sadoul P
    Sem Hop; 1984 Feb; 60(9):643-58. PubMed ID: 6324374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of seaprose on the rheology of bronchial mucus in patients with chronic bronchitis. A double-blind study vs placebo.
    Braga PC; Moretti M; Piacenza A; Montoli CC; Guffanti EE
    Int J Clin Pharmacol Res; 1993; 13(3):179-85. PubMed ID: 8225701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of seaprose on erythromycin penetration into bronchial mucus in bronchopulmonary infections.
    Braga PC; Piatti G; Grasselli G; Casali W; Beghi G; Allegra L
    Drugs Exp Clin Res; 1992; 18(3):105-11. PubMed ID: 1425205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Current concepts of bronchial fluidifiers (author's transl)].
    Polu JM; Puchelle E; Sadoul P
    Nouv Presse Med; 1978 Feb; 7(7):557-63. PubMed ID: 643582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Round table. Relevant controls and usefulness of treatments modifying bronchial secretions (author's transl)].
    Bull Physiopathol Respir (Nancy); 1973; 9(2):417-71. PubMed ID: 4778961
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of the elastic and viscous components of bronchial mucus before and after S-carboxymethylcysteine-Lys treatment.
    Braga PC; Bossi R; Allegra L
    Int J Clin Pharmacol Res; 1984; 4(2):121-7. PubMed ID: 6469438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucoactive agents for airway mucus hypersecretory diseases.
    Rogers DF
    Respir Care; 2007 Sep; 52(9):1176-93; discussion 1193-7. PubMed ID: 17716385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mucolytic action "in vitro" of the methyl ester of cysteine compared with the action of N-acetyl-L-cysteine].
    Saia B; Terribile P; Galzigna L
    Minerva Med; 1967 Nov; 58(88):3773-5. PubMed ID: 6074929
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of the rheological properties of bronchial secretions in the mucociliary transport at the bronchial surface.
    Puchelle E; Polu JM; Zahm JM; Sadoul P
    Eur J Respir Dis Suppl; 1980; 111():29-34. PubMed ID: 6938407
    [No Abstract]   [Full Text] [Related]  

  • 12. The pharmacologic approach to airway clearance: mucoactive agents.
    Rubin BK
    Respir Care; 2002 Jul; 47(7):818-22. PubMed ID: 12088552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Action mechanisms of cough suppressants and their clinical application].
    PÅ‚usa T
    Pol Merkur Lekarski; 2014 Jan; 36(211):48-53. PubMed ID: 24645580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Biochemical and enzymatic characteristics of bronchial secretions and their changes during treatment with mucolytic drugs].
    Olivieri D; Bocchino M; Marzo C
    Arch Monaldi; 1974; 29(3-4):283-308. PubMed ID: 4463914
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical value of liquifying drugs of bronchial secretions].
    Molina C; Aiache JM; Pradelle J; Brun J; Cheminat JC
    Poumon Coeur; 1970; 26(1):91-102. PubMed ID: 4393035
    [No Abstract]   [Full Text] [Related]  

  • 16. Mucolytics, expectorants, and mucokinetic medications.
    Rubin BK
    Respir Care; 2007 Jul; 52(7):859-65. PubMed ID: 17594730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Metabolism of 4-carbomethoxythiazolidine chlorohydrate to cysteine through human expectorate and lung homogenates, and its action on glycoproteins of mucus].
    Conte A; Ronca G
    Boll Chim Farm; 1990; 129(10-11):45S-48S. PubMed ID: 2102700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucolytics: when dispensable, when necessary?
    Dorow P
    Lung; 1990; 168 Suppl():622-6. PubMed ID: 2117172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rheological assessment of mucolytic agents on sputum of chronic bronchitics.
    Dippy JE; Davis SS
    Thorax; 1969 Nov; 24(6):707-13. PubMed ID: 5350721
    [No Abstract]   [Full Text] [Related]  

  • 20. [Studies on the viscosity-reducing properties of fominoben in tracheal and bronchial secretions in man].
    Krug F
    Arzneimittelforschung; 1973 Feb; 23():Suppl 2a:374-5. PubMed ID: 4740123
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.